Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
5.49
+0.04 (0.73%)
At close: Apr 28, 2026, 4:00 PM EDT
5.49
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Atossa Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 15.96 | 13.5 | 14.04 | 12.61 | 11.31 | |
| Research & Development | 21.19 | 14.12 | 17.33 | 15.08 | 9.21 | |
| Operating Expenses | 37.14 | 27.62 | 31.38 | 27.69 | 20.52 | |
| Operating Income | -37.14 | -27.62 | -31.38 | -27.69 | -20.52 | |
| Interest & Investment Income | 2.38 | 4.05 | 4.34 | 0.88 | 0.01 | |
| Other Non Operating Income (Expenses) | -0.01 | -0.22 | -0.07 | -0.15 | -0.09 | |
| EBT Excluding Unusual Items | -34.77 | -23.79 | -27.1 | -26.96 | -20.61 | |
| Gain (Loss) on Sale of Investments | - | -1.71 | -2.99 | - | - | |
| Pretax Income | -34.77 | -25.5 | -30.09 | -26.96 | -20.61 | |
| Earnings From Continuing Operations | -34.77 | -25.5 | -30.09 | -26.96 | -20.61 | |
| Net Income | -34.77 | -25.5 | -30.09 | -26.96 | -20.61 | |
| Net Income to Common | -34.77 | -25.5 | -30.09 | -26.96 | -20.61 | |
| Shares Outstanding (Basic) | 9 | 8 | 8 | 8 | 8 | |
| Shares Outstanding (Diluted) | 9 | 8 | 8 | 8 | 8 | |
| Shares Change (YoY) | 2.63% | -0.18% | -0.43% | 8.27% | 934.13% | |
| EPS (Basic) | -4.04 | -3.04 | -3.58 | -3.19 | -2.64 | |
| EPS (Diluted) | -4.04 | -3.04 | -3.58 | -3.19 | -2.64 | |
| Free Cash Flow | -29.79 | -21.05 | -20.96 | -20.79 | -16.48 | |
| Free Cash Flow Per Share | -3.46 | -2.51 | -2.49 | -2.46 | -2.11 | |
| EBITDA | -37.13 | -27.6 | -31.35 | -27.68 | -20.5 | |
| D&A For EBITDA | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
| EBIT | -37.14 | -27.62 | -31.38 | -27.69 | -20.52 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.